Literature DB >> 27469565

Oral squamous cell carcinoma: diagnostic markers and prognostic indicators.

D Lauritano1, A Lucchese2, M Contaldo2, R Serpico2, L Lo Muzio3, F Biolcati4, F Carinci4.   

Abstract

OSCC is the most frequent malignant tumour of the oral cavity, accounting for more than 90% of malignant tumours of this anatomic region and it often arises from precursor lesions. Aside from tobacco and alcohol consumption, further determinants have been considered to increase the risk of OSCC development, such as micronutrient deficiencies, chronic traumatism, poor oral hygiene and viruses. Recurrence, survival and conversely, mortality depends on numerous and different biological, histological, macroscopic and microscopic factors that have been investigated in order to define causes, to help diagnosis and to refine appropriate treatments that perfectly fit with the different features of OSCCs. For this purpose, during the last decades, the improvement of scientific technologies and molecular analyses have allowed to investigate markers and genetic and epigenetic factors, in order to clarify their responsibilities related to early diagnosis and OSCC progression and prognosis in order to address them as targets in future selective and individually-shaped therapies. This review will focus on the etiology, advances in diagnostic markers and prognostic indicators for oral cancers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27469565

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN: 0393-974X            Impact factor:   1.711


  6 in total

1.  Anti-Cancer Effects of Traditional Medicinal Herbs on Oral Squamous Cell Carcinoma.

Authors:  Ali Dehghani Nazhvani; Najmeh Sarafraz; Fatemeh Askari; Fahimeh Heidari; Mahboobeh Razmkhah
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

2.  Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.

Authors:  Kwame Osei-Sarfo; Lorraine J Gudas
Journal:  PLoS One       Date:  2019-04-12       Impact factor: 3.240

3.  The Emerging Role of NANOG as an Early Cancer Risk Biomarker in Patients with Oral Potentially Malignant Disorders.

Authors:  Juan C de Vicente; Tania Rodríguez-Santamarta; Juan P Rodrigo; Eva Allonca; Aitana Vallina; Anusha Singhania; Paula Donate-Pérez Del Molino; Juana M García-Pedrero
Journal:  J Clin Med       Date:  2019-09-03       Impact factor: 4.241

4.  Identification of potential CpG sites for oral squamous cell carcinoma diagnosis via integrated analysis of DNA methylation and gene expression.

Authors:  Le Chen; Dong Wang
Journal:  World J Surg Oncol       Date:  2021-01-19       Impact factor: 2.754

5.  Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.

Authors:  Ming Li; Feng Gao; Xinfang Yu; Qing Zhao; Li Zhou; Wenbin Liu; Wei Li
Journal:  J Exp Clin Cancer Res       Date:  2020-05-14

6.  Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways.

Authors:  Yanshu Li; Shiheng Jia; Wei Dai
Journal:  Drug Des Devel Ther       Date:  2020-02-25       Impact factor: 4.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.